Latest News

 Filter by Provider

(BPT) - For anyone interested in healthy aging, it can seem overwhelming to keep up with the latest trends. The good news is, many trends today focus on holistic approaches aiming to support your body's natural processes.

Soligenix reports positive Phase 2a trial results for SGX945 in Behçet's disease, showing strong efficacy and no adverse events compared to apremilast.

A blowout quarter from Palantir may not be enough to justify its current price tag.

The GBP/USD pair dropped to 1.3252, its lowest level since 11 May 2025, as a resurgent US dollar and disappointing UK economic data weighed on the pound.

Aerospace and defense company Huntington Ingalls (NYSE:HII) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.5% year on year to $3.08 billion. Its GAAP profit of $3.86 per share was 17.2% above analysts’ consensus estimates.

The two supermajors are poised to be working closely together.

Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% year on year to $2.81 billion. On the other hand, next quarter’s revenue guidance of $2.87 billion was less impressive, coming in 1% below analysts’ estimates. Its non-GAAP profit of $0.59 per share was 3.2% below analysts’ consensus estimates.

Fed Chair Powell promises to contain tariff-driven inflation while navigating rising risks to both sides of the Fed’s dual mandate.

International Paper Co (IP) shares drop 7% after Q2 earnings miss estimates despite revenue growth. Adjusted EPS of $0.20 fell short by 51.1%, sparking investor concerns.

Marine transportation service company Kirby (NYSE:KEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.8% year on year to $855.5 million. Its GAAP profit of $1.67 per share was 2.7% above analysts’ consensus estimates.

Amicus Therapeutics (FOLD) beats Q2 2025 revenue and EPS estimates, driven by strong growth in Galafold and Pompe disease therapies, sparking a 2.77% pre-market rally.

The leading aftermarket auto parts retailer continues to impress investors.

Balchem Corp (BCPC) reported Q2 2025 earnings in line with estimates, with revenue at $255.5M and EPS at $1.27. Shares rose slightly in pre-market trading.

The volatility sparked $355.95 million in liquidations over the past day, according to Coinglass data.

Capital Clean Energy Carriers Corp (CCEC) missed Q2 2025 revenue and EPS estimates, with shares down 1.45% pre-market. Weak performance reflects industry challenges, but no major sell-off occurred.

Fast-food chain Shake Shack (NYSE:SHAK) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 12.6% year on year to $356.5 million. Its non-GAAP profit of $0.44 per share was 16.9% above analysts’ consensus estimates.

Bristol-Myers Squibb (BMY) beats Q2 2025 revenue and EPS estimates, driving a 2.9% pre-market stock surge. Strong oncology, immunology, and cardiovascular drug sales fuel growth.

Howmet Aerospace Q2 2025 earnings beat estimates with $2.053B revenue and $0.91 EPS, driven by strong aerospace demand. Stock gains reflect bullish outlook.

Brookfield Infrastructure (BIP) Q2 2025 earnings beat estimates with $5.43B revenue and $0.81 EPS. Stock shows mixed performance despite strong results.

Commerce.com (BIGC) reported Q2 2025 results with mixed performance—revenue slightly missed estimates while EPS beat. Rebranding to Commerce.com and new AI partnerships aim for growth.

Building materials company Builders FirstSource (NYSE:BLDR) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 5% year on year to $4.23 billion. The company’s full-year revenue guidance of $15.2 billion at the midpoint came in 6.6% below analysts’ estimates. Its non-GAAP profit of $2.38 per share was 1.6% above analysts’ consensus estimates.

Huntington Ingalls Industries (HII) beats Q2 2025 earnings with $3.08B revenue and $3.86 EPS, driving a 5.2% pre-market stock surge.

Nike confirms a bullish reversal with an impulsive recovery, so after a correction, it can send the price even higher by Elliott wave theory.

Donnelley Financial Solutions (DFIN) reported mixed Q2 2025 results, with EPS beating estimates at $1.49 but revenue missing at $218.1M. Shares dipped pre-market amid investor caution.

These stocks have all surged more than 1,000% since August 2020.

Vulcan Materials (VMC) Q2 2025 earnings missed estimates with $2.10B revenue and $2.45 EPS, causing a 4% pre-market drop. Full-year guidance remains unchanged.

Corporate treasuries and spot ETFs are rapidly consolidating their hold on Ethereum (CRYPTO: ETH), with combined on-chain and off-chain holdings now surpassing $32 billion.

Laureate Education (NASDAQ:LAUR) beat Q2 2025 earnings and revenue estimates, raising full-year guidance. Stock rose modestly as strong enrollment in Mexico and Peru drives growth.

PPL Corp reports mixed Q2 2025 results with EPS missing estimates but revenue slightly beating forecasts. Shares dip 1.5% premarket amid investor caution.

ATI Inc. reports mixed Q2 2025 earnings, with EPS beating estimates but revenue missing. Aerospace & defense sales surged, though stock dipped 8% pre-market. Boeing deal strengthens outlook.

Apple (AAPL) to report Q3 earnings on July 31, with expected EPS of $1.42 and revenue of $89.04B. Wedbush analyst maintains $270 price target and 0.50% annual dividend yield. Investors can earn $500/month with $1,206,009 investment, or $100/month with $241,244. Dividend yield changes with dividend payments and stock price fluctuations. AAPL shares closed at $209.05 on Wednesday.

Affiliated Managers Group (AMG) reported mixed Q2 2025 results, beating EPS estimates but missing revenue targets, causing a pre-market stock dip. Analysts remain cautious amid revenue concerns.

Excluding food and energy, the PCE price index increased 2.8% from one year ago.

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

This soaring ETF should be a consideration for many investors.

Terex Corp (NYSE:TEX) reported strong Q2 2025 earnings, beating revenue and EPS estimates. Full-year guidance remains optimistic, driven by growth in Materials Processing and Aerial Work Platforms segments.

Satellite radio and media company Sirius XM (NASDAQ:SIRI) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.8% year on year to $2.14 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $8.5 billion at the midpoint. Its GAAP profit of $0.57 per share was 26.3% below analysts’ consensus estimates.

Peabody Energy (NYSE: BTU) Q2 2025 results missed revenue and EPS estimates, causing a 7.8% pre-market drop. Operational improvements noted, but wider loss and revenue shortfall weigh on sentiment.